Interaction of zalcitabine with human organic anion transporter 1

Pharmazie

Volumn 61, Issue 5, 2006, Pages 491-492

  Jin, Ming Ji ^a   Han, Hyo Kyung ^a  

^a Chosun University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; ORGANIC ANION TRANSPORTER 1; ZALCITABINE;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG INHIBITION; DRUG TRANSPORT; GENETIC TRANSFECTION; IC 50; KIDNEY TUBULE ABSORPTION; NONHUMAN; URINARY EXCRETION;

ANIMALS; ANTI-HIV AGENTS; CHO CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRICETINAE; HUMANS; ORGANIC ANION TRANSPORT PROTEIN 1; P-AMINOHIPPURIC ACID; REVERSE TRANSCRIPTASE INHIBITORS; STIMULATION, CHEMICAL; ZALCITABINE;

EID: 33646561528     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Abel S, Nichols DJ, Brearley CJ, Eve MD (2000) Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide. Br J Clin Pharmacol 49: 64-71.
2. Ayrton A, Morgan P (2001) Role of transport proteins in drag absorption, distribution and excretion. Xenobiotica 31: 469-497.
3. Burckhardt BC, Burckhardt G (2003) Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 146: 95-158.
4. Dahlberg JE, Mitsuya H, Blam SB, Broder S, Aaronson SA (1987) Broad spectrum antiretroviral activity of 2′,3′-dideoxynucleosides. Proc Natl Acad Sci USA 84: 2469-2473.
5. Gibbs JE, Thomas SA (2002) The distribution of the anti-HIV drug, 2′,3′-dideoxycytidine (ddC), across the blood-brain and blood-cerebrospinal fluid barriers and the influence of organic anion transport inhibitors. J Neurochem 80: 392-404.
6. Ho ES, Lin DC, Mendel DB, Cihlar T (2000) Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J Am Soc Nephrol 11: 383-393.
7. Ibrahim SS, Boudinot FD (1989) Pharmacokinetics of 2′,3′- dideoxycytidine in rats: Application to interspecies scale-up. J Pharm Pharmacol 41: 829-834.
8. Khamdang S, Takeda M, Noshiro R, Narikawa S, Enomoto A, Anzei A, Piyachaturawat P, Endou H (2002) Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 303: 534-539.
9. Kim RB (2000) Transporters in drug disposition. Curr Opin Drug Discov Devel 3:94-101.
10. Klecker RW, Collins JM, Yarchoan RC, Thomas R, McAtee N, Broder S, Myers CE (1988) Pharmacokinetics of 2′,3′-dideoxycytidine in patients with AIDS and related disorders. J Clin Pharmacol 28: 837-842.
11. Massarella JW, Nazareno LA, Passe S, Min B (1996) The effect of probenecid on the pharmacokinetics of zalcitabine in HIV-positive patients. Pharm Res 13: 449-452.
12. Mulato AS, Ho ES, Cihlar T (2000) Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1. J Pharmacol Exp Ther 295: 10-15.
13. Sekine T, Cha SH, Endou H (2000) The multispecific organic anion transporter (OAT) family. Pflügers Arch-Eur J Physiol 440: 337-350.
14. Yamazaki M, Suzuki H, Sugiyama Y (1996) Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics. Pharm Res 13: 497-513.